Ticker League

Estimates for Zimmer Biomet Holdings (ZBH)

Analyst consensus revenue & EPS estimates for Zimmer Biomet Holdings (ZBH) — Q2 2026. Compare the numbers and make your own prediction.

Consensus EPS · Q2 2026

$2.01

Consensus revenue · Q2 2026

$2.1B

Analysts

15

Expected report

Aug 5, 2026

Before open
Upcoming earnings
Locks in 8 days 16 hours · BMO: Locks 8:00 PM ET previous day
Revenue$2.1B$2.1B $2.2B
EPS$2.01$1.98 $2.05

What to watch

  • Analyst ratings: Downgrades trending
Make your prediction

Analyst consensus

Based on estimates from 15 analysts.

  • Revenue$2.1B
  • EPS$2.01
  • EBITDA$563.3M
  • EBIT$280.5M
  • Net income$393.7M

Historical beat/miss

Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.

  • Q1 2026+0.8%+12.0%

Estimate revisions

How analyst consensus estimates have changed over the past 90 days.

Collecting data

Revision trends appear once we have collected at least two daily snapshots for this period.

Community vs analysts

See how the TickerLeague crowd's forecast stacks up against Wall Street.

Be the first to predict

No community consensus for Zimmer Biomet Holdings (ZBH) Q2 2026 yet. Make a prediction to start the crowd forecast.

Make your prediction

Analyst price target

Based on price targets from 1 analyst.

Low
$83.00
Consensus
$92.86
Median
$92.00
High
$105.00
Current
$91.35
Upside
+1.7%

Upside calculated vs most recent trading price of $91.35.

Analyst ratings

Consensus: Hold — based on 42 analyst ratings.

Buy 17Hold 22Sell 3

24-month trend

Recent analyst actions

  • Jul 9, 2026BMO CapitalMarket Perform
  • Jul 6, 2026Evercore ISI GroupOutperform
  • May 28, 2026CitigroupNeutral
  • Apr 29, 2026Wells FargoEqual Weight
  • Apr 29, 2026Truist SecuritiesHold
  • Apr 29, 2026StifelBuy
  • Apr 29, 2026JP MorganNeutral
  • Apr 29, 2026CitizensMarket Outperform
  • Apr 29, 2026CitigroupNeutral
  • Apr 29, 2026BarclaysUnderweight

Frequently asked questions